Cardiac syndrome X versus metabolic syndrome X

International Journal of Cardiology

Volumn 119, Issue 2, 2007, Pages 137-138

  Cheng, Tsung O ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC SYNDROME X; CORONARY ARTERY DISEASE; CORONARY SYNDROME X; DYSLIPIDEMIA; EDITORIAL; GLUCOSE INTOLERANCE; HEART DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; MITRAL VALVE PROLAPSE; PRIORITY JOURNAL; THORAX PAIN;

BIOLOGICAL TRANSPORT, ACTIVE; HUMANS; LITHIUM; METABOLIC SYNDROME X; MICROVASCULAR ANGINA; SODIUM;

EID: 34249340051     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.06.062     Document Type: Editorial

References (14)

1. Kemp H.G. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 32 (1973) 375-376
2. Reaven G.M. Role of insulin resistance in human disease (Banting lecture 1988). Diabetes 37 (1988) 1595-1607
3. Dean J.D., and Jones C.J.H. Hyperinsulinaemia and microvascular angina ("syndrome X"). Lancet 337 (1991) 456-457
4. Gaspardone A., Ferri C., Crea F., et al. Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X. A potential link between cardiac and metabolic syndrome X. J Am Coll Cardiol 32 (1998) 2031-2034
5. Jadhav S.T., Ferrell W.R., Petrie J.R., et al. Microvascular function, metabolic syndrome and novel risk factor status in women with cardiac syndrome X. Am J Cardiol 97 (2006) 1727-1731
6. Morris S.J., Shore A.C., and Tooke J.E. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 38 (1995) 1337-1344
7. Rossi M., Taddei S., Fabbri A., et al. Cutaneous vasodilation to acetylcholine in patients with essential hypertension. J Cardiovasc Pharmacol 29 (1997) 406-411
8. Khan F., Litchfield S.J., Stonebridge P.A., and Belch J.J. Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease. Vasc Med 4 (1999) 233-238
9. Cannon III R.O. The cardiovascular syndrome X: how to recognize and how to manage. ACC Curr J Rev 8 4 (1999) 27-29
10. Cheng T.O. Mitral valve prolapse. Dis -Mon 33 (1987) 481-534
11. Cheng T.O. Syndrome X. ACC Curr J Rev 9 3 (2000) 102
12. Cheng T.O. Syndrome X. N Zealand Med J 107 (1994) 139
13. Cheng T.O. Syndrome X confusion. Phys Sportsmed 22 10 (1994) 49
14. Cheng T.O. Characteristics of the metabolic syndrome X. Eur Heart J 14 (1993) 143